+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
From
From
Ranibizumab (Lucentis) Biosimilars Pipeline Review - Product Thumbnail Image

Ranibizumab (Lucentis) Biosimilars Pipeline Review

  • Report
  • November 2024
  • Global
From
Aflibercept (Eylea) Biosimilars Pipeline Review - Product Thumbnail Image

Aflibercept (Eylea) Biosimilars Pipeline Review

  • Report
  • November 2024
  • Global
From
From
Global Minoxidil Market 2020-2025 - Product Thumbnail Image

Global Minoxidil Market 2020-2025

  • Report
  • June 2021
  • 58 Pages
  • Global
From
Antihypertensives: Global Markets to 2023 - Product Thumbnail Image

Antihypertensives: Global Markets to 2023

  • Report
  • January 2019
  • 144 Pages
  • Global
From
Cardiovascular Drugs: Global Markets to 2022 - Product Thumbnail Image

Cardiovascular Drugs: Global Markets to 2022

  • Report
  • March 2018
  • 174 Pages
  • Global
From
Global Heparin Market Outlook 2030 - Product Thumbnail Image

Global Heparin Market Outlook 2030

  • Report
  • October 2021
  • 154 Pages
  • Global
From
Precision Cardiometabolic Growth Opportunities - Product Thumbnail Image

Precision Cardiometabolic Growth Opportunities

  • Report
  • November 2023
  • 66 Pages
  • Global
From
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more